Theoretical basis of optimal therapy for individual patients in chronic myeloid leukemia: A mathematical approach

Abstract

Even if the successful pharmacological therapy for chronic myeloid leukemia has reached today a near normal life expectancy in a patient diagnosed with this malignancy, almost one in four patients will change the line of tyrosin-kinase inhibitors during therapy, may it be due to poor response of due to intolerance to therapy. In this paper, starting from a mathematical characterization of the chronic phase in myeloid leukemia, a theoretical investigation of optimal therapy is undertaken as base for further pharmaceutical research and personalized treatment protocols.

Authors

Lorand Gabriel Parajdia
Department of Mathematics, Babeş-Bolyai University, Cluj-Napoca,Romania

Radu Precup
Department of Mathematics Babes-Bolyai University, Cluj-Napoca, Romania

Delia Dima
Department of Hematology, Ion Chiricuţă Clinical Cancer Center, Cluj-Napoca, Romania

Vlad Moisoiu
Department of Hematology, Ion Chiricuţă Clinical Cancer Center, Cluj-Napoca, Romania
IMOGEN Research Institute, County Clinical Emergency Hospital, Cluj-Napoca, Romania

Ciprian Tomuleasa
Department of Hematology, Ion Chiricuţă Clinical Cancer Center, Cluj-Napoca, Romania

Keywords

Mathematical model; Chronic myeloid leukemia; Dynamic system; Optimization problem

Paper coordinates

L. G. Parajdi, R. Precup, D. Dima, V. Moisoiu, C. Tomuleasa, Theoretical basis of optimal therapy for individual patients in chronic myeloid leukemia: A mathematical approach, Journal of Interdisciplinary Mathematics 23:3 (2020), 669-690, https://doi.org/10.1080/09720502.2019.1681699

PDF

??

About this paper

Journal

Journal of Interdisciplinary Mathematics

Publisher Name

Taylor and Francis Ltd.

Print ISSN
Online ISSN

09720502

google scholar link

Related Posts